Fresenius Medical Care announced today that it launched the newest version of its home hemodialysis (HHD) machine, the NxStage Versi HD with GuideMe software.

The new machine features enhancements designed to simplify treatment, increase ease of learning and improve user experience.

NxStage Versi HD with GuideMe software picked up FDA clearance in 2023. Fresenius Medical Care says its system has since picked up significant interest in the U.S. as large, mid-sized and independent dialysis providers continue to adopt the company’s latest home hemodialysis system.